Sick Leave and Productivity

How it works

Benefits

Dosage & preparation

Risks & contraindications

Comparisons

Highlighted claims

• CHD patients with insomnia were almost four times more likely to be on sick leave at baseline than those without insomnia (23% vs 6%; RR = 3.90). — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
• Norway's tax-funded healthcare system means insomnia-related excess hospital use and productivity loss translate directly into public expenditure. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
• Potential sick leave savings are substantially larger than healthcare savings, particularly under the 26-week sick leave duration scenario. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
• At the empirically observed 30–50% remission rate, projected 26-week sick leave savings range from €207,652 to €346,086 per 100 patients. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation
• A conservative estimate based on a mean reduction of 1.5 working days yields a modest but real saving of €444 per participant. — Potential benefits of group cognitive–behavioural therapy for insomnia in outpatients with coronary heart disease versus usual care: an early economic evaluation